C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/00 (2006.01) A01K 67/027 (2006.01) C07K 16/00 (2006.01) C12N 5/10 (2006.01) C12N 5/12 (2006.01) C12N 5/16 (2006.01) C12N 15/00 (2006.01) C12N 15/13 (2006.01) C12N 15/85 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2438818
The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
L'invention concerne des hybridomes, des myélomes et des lymphocytes B génétiquement modifiés. Elle a également trait à l'utilisation d'hybridomes, de myélomes et de lymphocytes B génétiquement modifiés dans des procédés de fabrication d'anticorps monoclonaux. L'invention concerne aussi des populations d'hybridomes et de lymphocytes B pouvant être utilisées pour fabriquer un anticorps monoclonal voulu.
Laterza Vince
Meagher Richard B.
Abeome Corporation
Gowling Lafleur Henderson Llp
University Of Georgia Research Foundation Inc.
LandOfFree
Rapid production of monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid production of monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid production of monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1754723